AstraZeneca is an international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. 
AstraZeneca will focus on strengthening its pipeline, driving top-line sales growth and making productivity improvements. A core priority for the company is to ensure that its growing range of candidate drugs (compounds with the potential to become new medicines) are developed effectively to meet the future needs of its patients.
However, the company will also continue to challenge all elements of its business to drive productivity and provide for the increased investment to support the achievement of its strategic objectives.
AstraZeneca states that it faces “some tough challenges” including the growing pressure on the price of its marketed products, higher costs and regulatory hurdles for the development of new products and a competitive marketplace, including challenges to its patents.
Astra-Zeneca with headquarters in London, UK, has sales of around $33bn and about 65,000 employees (2009).
ICIS Chemical Business magazine has unveiled the ICIS Top 100 Chemical Companies, with rankings based on 2008 sales.
A PDF of the ICIS Top 100 Chemical Companies is available for download on ICIS connect.
See the article and analysis of the ICIS Top 100 on ICIS news.
Key Personnel
Non-executive chairman: Louis Schweitzer
Chief executive officer: David Brennan
Chief financial officer: Simon Lowth
Non-executive director: Jane Henney
Non-executive director: Marcus Wallenberg
Non-executive director: Nancy Rothwell
Non-executive director: Bo Angelin
Non-executive director: Michele Hooper
Non-executive director: John Varley
Non-executive director: John Buchanan
Non-executive director: Jean-Philippe Courtois
Non-executive director: Rudy Markham
(Updated August 2009)
Please see ICIS presents the Top 40 Power Players on ICIS Chemical Business or alternatively download the ICIS Top 40 chemical industry power players 2009 complete listing on ICIS Connect.
Contacts
AstraZeneca
15 Stanhope Gate
London W1Y 1LN
UK
Tel.: +44 020 7304 5000
Fax: +44 020 7304 5183
www.astrazeneca.com
AstraZeneca
Company Structure
AstraZeneca is an international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services.
More about AstraZeneca Structure
AstraZeneca
Strategy & Financial Highlights
AstraZeneca will focus on strengthening its pipeline, driving top-line sales growth and making productivity improvements. It says that to manage the challenges of its business environment and to maximise the opportunities to deliver sustainable, profitable growth it will focus its efforts on the following strategic plan. (Edited from “Chairman's statement”, “Chief executive officer’s review”, and “Strategy”, AstraZeneca, annual report). ICIS also provides you with key financial data listed in table form.
More about AstraZeneca Strategy & Financial Highlights
News:
Get news on AstraZeneca plus the latest chemical news, information, data, market movements and analysis
in one place with ICIS news
Search:
Find details on other chemical companies and suppliers with
ICIS search
Newsletters:
ICIS offers a range of FREE e-newsletters to ensure that you don't miss out on the latest development and key market intelligence in your industry. If you want the latest news sent to your inbox, sign up for ICIS e-newsletters today.
Plants and projects:
Find out more about current and planned chemical plants and projects by subscribing to our comprehensive database